Burcon NutraScience Corporation

Burcon NutraScience Corporation

BRCNF
Burcon NutraScience CorporationUS flagOther OTC
1.38
USD
+0.00
- -
17.52MMarket Cap
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
0.03
0.03
0.03
0.02
0.01
0.01
0.01
0.04
0.03
0.06
0.03
0.05
0.18
0.18
Basic EPS, GAAP
-1.85
-1.95
-1.82
-1.57
-1.48
-1.1
-0.97
-0.1
-1.56
-3.86
-1.01
-1.06
-1.12
-1.12
Free Cash Flow per Basic Share
-1.62
-1.44
-1.37
-1.3
-1.22
-0.96
-1.04
-0.95
-1.09
-0.97
-0.8
-0.74
-0.8
-0.8
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-3.23
-2.96
-3.5
-3.63
-4.1
-4.71
-0.07
2.43
0.81
-3.05
-2.72
-2.4
-2.6
-2.6
Tangible Book Value per Share
0.55
1.12
0.73
0.78
0.29
-0.75
4.22
4.91
3.16
-0.44
-0.2
0.09
-0.91
-0.91
Basic Weighted Avg Shares
3
3
4
4
4
4
5
6
7
7
7
8
13
13
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
2
2
Operating Margin (%)
-6,601.23
-6,144.41
-6,095.33
-6,508.51
-11,483.4
-10,857.45
-11,672.79
-1,767.54
-4,290.3
-2,067.68
-3,807.23
-2,018.75
-502.33
-502.33
Depreciation Expense
1
1
1
- -
- -
- -
- -
- -
- -
1
1
1
2
2
Net Income, GAAP
-6
-7
-7
-6
-6
-5
-5
-1
-10
-25
-7
-8
-14
-14
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
-6,293.6
-6,243.11
-6,175.18
-6,576.05
-11,471.79
-11,890.83
-14,882.42
-238.74
-5,982.59
-6,969.87
-4,038.96
-2,166.98
-629.38
-628.94
Working Capital
1
3
2
4
3
-4
14
13
7
1
4
4
-11
-11
LT Debt
- -
- -
- -
2
2
- -
7
- -
- -
5
6
19
14
14
Total Equity
4
6
4
4
2
-2
23
36
28
4
5
7
-6
-6
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -
- -
-100.28
- -
- -
- -
- -
- -

Capital Structure

FRC

in mil. unless spec.
Sep'26
Dec'26
Mar'26
ST Debt
10
10
11
LT Borrowings
- -
1
- -
LT Finance Leases
13
13
13
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
13
13
13
Market Capitalization
26
21
25

Working Capital

FRC

in mil. unless spec.
Sep'26
Dec'26
Mar'26
Total Current Assets
3
3
2
Cash, Cash Equivalents & STI
2
1
1
Accounts Receivable, Net
- -
- -
1
Inventories
- -
1
1
Total Current Liabilities
11
12
13
Payables & Accruals
1
2
2
ST Debt
10
10
11
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-165.98%
-46.34%
-183.51%
Free Cash Flow
9.72%
15.1%
73.99%
Net Income, GAAP
160.19%
344.27%
72.46%
Sales/Revenue/Turnover
125.84%
125.97%
493.78%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
1
1
2

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.27
-0.19
-0.28
- -
-1.01
2025
-0.22
-0.27
-0.25
- -
-1.06
2026
-0.27
-0.28
-0.28
- -
-1.12

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

APIChatGPT
CEO
Kip Underwood
Full Time Employees
14
Sector
Consumer Defensive
Industry
Packaged Foods
Address
1946 West Broadway Vancouver BC Canada V5Z 1K5
IPO Date
Apr 5, 2010
Website
burcon.ca
Business
Burcon NutraScience Corporation (TSX: BU; OTCQB: BRCNF) develops and commercializes innovative plant-based protein ingredients and technologies for the global food and beverage industries. The company offers a portfolio of high-performance proteins derived from pea (including Peazazz and Peazac for dairy alternatives, beverages, bars, baked goods and meat substitutes), canola (including Puratein for meat alternatives and nutrition bars, Supertein for non-dairy desserts and whipped toppings, and Nutratein for meat and egg alternatives), soy (including CLARISOY for sports nutrition and fruit beverages), fava, sunflower seed, hempseed and protein blends; it also provides pilot plant processing, scale-up validation, product development, consulting and contract services utilizing its 10,000 square foot Winnipeg Technical Centre equipped for extraction, membrane filtration, drying and analytical testing. Founded in 1998 and headquartered in Vancouver, British Columbia, Canada, with operations including a technical centre in Winnipeg, Manitoba, and through subsidiaries such as Burcon NutraScience (MB) Corp., the company targets food and beverage manufacturers seeking sustainable, clean-label solutions for plant-based products serving health-conscious consumers worldwide, primarily in North America. In recent developments, Burcon expanded its service offerings in late 2024 with pilot-scale processing and innovation services to support partners in protein development and upcycling; formed a strategic alliance with RE ProMan, LLC, led by director John Vassallo, which completed the acquisition of a commercial protein production facility in Galesburg, Illinois, in March 2025 under a seven-year exclusive manufacturing agreement projected to enable commercial-scale production of its full protein portfolio, first-year sales of $1-3 million and profitability in 2026; and partnered with Puratos in 2024 to develop canola protein-enhanced bakery, patisserie and chocolate solutions. The company maintains a joint venture, Merit Functional Foods, focused on protein production in Manitoba, Canada, and holds an extensive patent portfolio covering its proprietary clean-label extraction and purification processes for multiple plant sources.

Company News

APIChatGPT
  • Is Burcon NutraScience (BRCNF) Stock Outpacing Its Consumer Staples Peers This Year?

  • Burcon NutraScience Corporation (BU:CA) Q4 2026 Earnings Call Transcript

  • Burcon Announces Fiscal 2026 Results

  • Burcon Announces Fiscal Year 2026 Conference Call and Presentation to be Held on June 24, 2026

  • Burcon Accelerates Growth & Achieves New Production Record

  • Burcon Announces Appointment of New Director

  • Burcon Closes Final Tranche of Non-Brokered Private Placement of Convertible Debentures of up to $6.9 Million

  • Burcon Achieves Record Production, Expands to More than 20 Buying Customers and Evaluates Additional Capacity Expansion

  • Burcon Closes Second Tranche of Non-Brokered Private Placement of Convertible Debentures of up to $6.9 Million

  • Burcon Announces Results of Shareholder Meeting

  • Burcon NutraScience Corporation (BU:CA) Shareholder/Analyst Call Prepared Remarks Transcript

  • Stonegate Updates Coverage on Burcon Nutrascience Corporation (BU) FY26 Q3

  • Burcon NutraScience Corporation (BU:CA) Q3 2026 Earnings Call Transcript

  • Burcon Announces Fiscal 2026 Third Quarter Results

  • Burcon Announces Details on Special Meeting of Shareholders and Amendment to Outstanding Warrants

  • Burcon Announces Fiscal 2026 Third Quarter Conference Call and Presentation to be Held on February 11, 2026

  • Burcon Increases Non-Brokered Private Placement of Convertible Debentures to $6.9 Million

  • Burcon Announces Closing of First Tranche of Non-Brokered Private Placement of Convertible Debentures

  • Burcon Highlights Strong Year of Execution and Commercial Momentum in Shareholder Letter

  • Burcon Insiders Increase Commitment to Participate in Non-Brokered Private Placement of Convertible Debentures